Abstract
Aberrant promoter methylation and the associated loss of gene expression is a common accompaniment of human cancers1. Nonetheless, it has been challenging to demonstrate in any given tumour that methylation of a specific gene was causal and not consequent to malignant transformation. In this regard, our attention was drawn to the genesis of gastric cancers in individuals with hereditary diffuse gastric cancer (HDGC). These individuals harbour germline mutations in the gene encoding E-cadherin, CDH1 (refs 2–4), but their cancers have consistently demonstrated absence of loss of heterozygosity at the CDH1 locus2,3,4. These findings suggested the hypothesis that CDH1 promoter methylation might function as the ‘second genetic hit’ in the genesis of these cancers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Jones, P. & Laird, P. Nature Genet. 21, 163–167 (1999).
Guilford, P. et al. Nature 392, 402–405 (1998).
Guilford, P. et al. Hum. Mutat. 14, 249– 255 (1999).
Richards, F. et al. Hum. Mol. Genet. 8, 607– 610 (1999).
Graff, J., Herman, J., Myohanen, S., Baylin, S. & Vertino, P. J. Biol. Chem. 272, 22322– 22329 (1997).
Lengauer, C., Kinzler, K. & Vogelstein, B. Proc. Natl Acad. Sci. USA 94, 2545–2550 (1997).
Ahuja, N., Li, Q., Mohan, M., Baylin, S. & Issa, J.-P. Cancer Res. 58, 5489– 5494 (1998).
Herman, J., Graff, J., Myohanen, S., Nelkin, B. & Baylin, S. Proc. Natl Acad. Sci. USA 93, 9821–9826 (1996).
Herman, J. et al. Proc. Natl Acad. Sci. USA 95, 6870– 6875 (1998).
Graff, J. et al. Cancer Res. 55, 5195– 5199 (1995).
Toyota, M. et al. Cancer Res. 59, 5438– 5442 (1999).
Myohanen, S., Baylin, S. & Herman, J. Cancer Res. 58, 591– 593 (1998).
Merlo, A. et al. Nature Med. 1, 686–692 (1995).
Stirzaker, C. et al. Cancer Res. 57, 2229– 2237 (1997).
Prowse, A. et al. Am. J. Hum. Genet. 60, 765– 771 (1997).
Acknowledgements
We thank A. Rajput and H. Hampel. This work was supported by PHS grants KO8 CA77676 (W.M.G.), RO1 CA67409, RO1 CA72160 (S.M.), P30 CA43703, P30CA16058, CA8485 and DK20593, and by the Health Research Council of New Zealand (P.J.G.). S.M. is an associate investigator of the Howard Hughes Medical Institute.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grady, W., Willis, J., Guilford, P. et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 26, 16–17 (2000). https://doi.org/10.1038/79120
Issue Date:
DOI: https://doi.org/10.1038/79120
This article is cited by
-
Severe induction of aberrant DNA methylation by nodular gastritis in adults
Journal of Gastroenterology (2024)
-
Current advances in understanding the molecular profile of hereditary diffuse gastric cancer and its clinical implications
Journal of Experimental & Clinical Cancer Research (2023)
-
Neural crest E-cadherin loss drives cleft lip/palate by epigenetic modulation via pro-inflammatory gene–environment interaction
Nature Communications (2023)
-
DNA methylome profiling of circulating tumor cells in lung cancer at single base-pair resolution
Oncogene (2021)
-
Case report: acute abdominal pain in a 37-year-old patient and the consequences for his family
BMC Gastroenterology (2020)